. 2025 Jul 31;13(9):e00643-25. doi: 10.1128/spectrum.00643-25

TABLE 2.

MIC distribution for MMA (n = 26)^a^,^b

Antibiotics	Number of isolates with MIC (μg/mL) of:
Antibiotics	<0.06	0.06	0.12	0.2	0.5	1	2	4	8	16	32	64	>64	>76/4	>152/8
CAM (3 days)	0	1	0	6	19	0	0	0	0	0	0	0	0
CAM (14 days)	0	0	0	6	15	5	0	0	0	0	0	0	0
AZM (3 days)	0	0	0	0	7	4	12	3	0	0	0	0	0
AZM (14 days)	0	0	0	0	4	3	9	10	0	0	0	0	0
AMK	0	0	0	0	0	0	0	4	21	1	0	0	0
TOB	0	0	0	0	0	0	0	3	8	15	0	0	0
IPM	0	0	0	0	0	0	0	1	12	9	3	1	0
MEPM	0	0	0	0	0	0	0	0	0	1	4	9	12
FRPM	0	0	0	0	0	0	0	0	0	0	0	1	25
LVFX	0	0	0	0	0	0	0	0	4	4	9	9	0
STFX	0	0	0	0	3	3	12	8	0	0	0	0	0
MFLX	0	0	0	0	0	0	2	4	3	17	0	0	0
DOXY	0	0	0	0	0	0	0	0	1	0	25	0	0
LZD	0	0	0	0	0	0	2	1	2	4	8	9	0
CLF	0	0	0	0	18	8	0	0	0	0	0	0	0
ST														2	24

^{^a}

Abbreviations: AMK, amikacin; AZM, azithromycin; CAM, clarithromycin; CLF, clofazimine; DOXY, doxycycline; FRPM, faropenem; IPM, imipenem; LVFX, levofloxacin; LZD, linezolid; MEPM, meropenem; MFLX, moxifloxacin; MIC, minimum inhibitory concentration; MMA, Mycobacterium abscessus subsp. massiliense; ST, sulfamethoxazole/trimethoprim; STFX, sitafloxacin; TOB, tobramycin.

^{^b}

Empty cells indicates that these MICs were not included as measurement items.